Skip to main content
Premium Trial:

Request an Annual Quote

Karius Secures $25M Loan

NEW YORK (GenomeWeb) — Karius announced today that it has reached a deal for a $25 million senior secured term loan from financing firm Oxford Finance.

Specific terms of the loan were not disclosed.

Redwood City, California-based Karius said it intends to use the money to continue commercialization of its diagnostic technologies, to fund clinical studies, and for research and development activities.

"Oxford Finance realizes Karius' potential to transform the diagnostic landscape for infectious diseases," Karius CEO Mickey Kertesz said in a statement. "This capital will enable Karius to help more patients by expanding its reach."

Karius recently launched a next-generation sequencing-based test capable of detecting over 1,000 pathogens — including bacteria, DNA viruses, fungi, mold, and protozoa — from microbial cell-free DNA in a single blood draw. Last month, the Stanford University spinout signed on São Paulo-based medical diagnostics firm Dasa to distribute the test in Brazil, and collaborators presented interim study results and anecdotal evidence on the assay.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more